Menu

Intersect ENT, Inc. XENT

Full chart Compare
Set alert

Price alert · XENT

All alert types
28.24 +28.24

Day range unavailable

52-week range unavailable

Revenue & Expenses

Revenue by
Income Tax Benefit → Expenses: $1.69MPropel Family Of Products → Revenue: $91.12MExpenses → Selling, General & Admin: $122.07MExpenses → Research & Development: $27.94MExpenses → Interest Expense: $6.44MExpenses → Other Expenses: $81.61MGross Profit → Expenses: $76.74MRevenue → Gross Profit: $76.74MRevenue → Cost of Revenue: $30.01MSinuva → Revenue: $9.07MNet Loss → Expenses: $159.63MVenSure, CUBE, And Accessories → Revenue: $6.56MIncome Tax Benefit$1.69MGross Profit$76.74MNet Loss$159.63MCost of Revenue$30.01MExpenses$238.06MSelling, General & Admin$122.07MResearch & Development$27.94MInterest Expense$6.44MOther Expenses$81.61MRevenue$106.75MPropel Family Of Products$91.12MSinuva$9.07MVenSure, CUBE, And Accessories$6.56M

Latest period ending Dec 31, 2021 · select a line to chart its full history

XENT annual income statement
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017
106.75M80.55M109.14M108.47M96.30M
76.74M50.25M87.37M85.86M80.80M
-141.04M-67.65M-45.39M-25.01M-17.60M
-159.63M-72.32M-42.99M-22.92M-16.36M
-4.80-2.22-1.37-0.76-0.56
XENT annual balance sheet
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017
56.28M31.02M20.65M9.46M19.84M
146.87M227.38M147.90M140.96M135.57M
215.94M160.37M29.84M19.97M18.36M
142.06M81.39M10.89M00
-69.07M67.01M118.06M120.99M117.22M
XENT annual cash flow
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017
-59.47M-35.69M-27.25M-13.84M-8.04M
49.18M-22.75M18.89M-10.00M9.25M
36.59M68.74M19.55M13.47M8.77M
-2.02M-873.00K-3.73M-2.12M-2.28M
25.91M10.37M11.19M-10.37M9.98M